Post by
stockfy on Feb 26, 2018 10:35am
Pre-production capital cost is $192 million
Proforma the recent placement of almost $80 million, DNA has about $125 million in cash. However, preproduction capital cost is $192 million, according to the latest presentation, which means that DNA will need to dilute again in the next months. $70 million is a significant amount. This might be another key factor for DNA's poor performance over the last six seven months. Could DNA find the extra cash without dilution? How?
Comment by
stockfy on Feb 26, 2018 11:03am
Perhaps, they could sell a non-core asset. Which one? How much? tia